Rosa María Ayala (R Ayala, Rosa Ayala)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 32

Top Venues

Cancers

American journal of hematology

Blood cancer journal

Clinical cancer research : an official journal of the American Association for Cancer Research

Hospital Universitario 12 de Octubre

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hospital Universitario 12 de Octubre Jul 01 2017

Spain

Head of Molecular Lab :: Hematology

Publications

Alberto Hernandez-Sanchez, Ángela Villaverde-Ramiro, Eduardo Arellano-Rodrigo, Marta Garrote, Iván Martín, Adrián Mosquera Orgueira, María-Teresa Gómez-Casares, Francisca Ferrer-Marín, Esperanza Such, Patricia Velez, Rosa María Ayala, Anna Angona, Natalia de Las Heras, Elena Magro, María-Isabel Mata-Vázquez, María-Laura Fox, Sonia González de Villambrosía, María-José Ramírez, Ana García, J Valentín García-Gutiérrez, Amparo Cáceres, María-Antonia Durán, Alicia Senín, José-María Raya, José Antonio González, Beatriz Cuevas, Blanca Xicoy Cirici, Manuel Mateo Pérez Encinas, Beatriz Bellosillo, Alberto Álvarez-Larrán, Jesús María Hernández-Rivas, Juan Carlos Carlos Hernández-Boluda, null null
The prognostic impact of non-driver gene mutations and variant allele frequency in primary myelofibrosis. American journal of hematology 99 (4) (2024)
Alberto Hernandez-Sanchez, Ángela Villaverde-Ramiro, Eduardo Arellano-Rodrigo, Marta Garrote, Iván Martín, Adrián Mosquera Orgueira, María-Teresa Gómez-Casares, Francisca Ferrer-Marín, Esperanza Such, Patricia Velez, Rosa María Ayala, Anna Angona, Natalia de Las Heras, Elena Magro, María-Isabel Mata-Vázquez, María-Laura Fox, Sonia González de Villambrosía, María-José Ramírez, Ana García, J Valentín García-Gutiérrez, Amparo Cáceres, María-Antonia Durán, Alicia Senín, José-María Raya, José Antonio González, Beatriz Cuevas, Blanca Xicoy Cirici, Manuel Mateo Pérez Encinas, Beatriz Bellosillo, Alberto Álvarez-Larrán, Jesús María Hernández-Rivas, Juan Carlos Carlos Hernández-Boluda, null null
The prognostic impact of non-driver gene mutations and variant allele frequency in primary myelofibrosis. American journal of hematology (2024)
Alba Rodríguez-García, Andrés Arroyo, Roberto García-Vicente, Maria Luz Morales, Rubén Gómez-Gordo, Pablo Justo, Clara Cuéllar, José María Sánchez-Pina, Nieves López-Muñoz, Rafael Alonso Fernández, Noemi Puig, Maria-Victoria Mateos-Manteca, Rosa María Ayala, Maria Dulcenombre Gómez-Garré, Joaquin Martinez Lopez, María Linares
Short-Chain Fatty Acid Production by Gut Microbiota Predicts Treatment Response in Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (4) (2024)
Alberto Hernandez-Sanchez, Ángela Villaverde-Ramiro, Eduardo Arellano-Rodrigo, Marta Garrote, Iván Martín, Adrián Mosquera Orgueira, María-Teresa Gómez-Casares, Francisca Ferrer-Marín, Esperanza Such, Patricia Velez, Rosa María Ayala, Anna Angona, Natalia de Las Heras, Elena Magro, María-Isabel Mata-Vázquez, María-Laura Fox, Sonia González de Villambrosía, María-José Ramírez, Ana García, J Valentín García-Gutiérrez, Amparo Cáceres, María-Antonia Durán, Alicia Senín, José-María Raya, José Antonio González, Beatriz Cuevas, Blanca Xicoy Cirici, Manuel Mateo Pérez Encinas, Beatriz Bellosillo, Alberto Álvarez-Larrán, Jesús María Hernández-Rivas, Juan Carlos Carlos Hernández-Boluda, null null
The prognostic impact of non-driver gene mutations and variant allele frequency in primary myelofibrosis. American journal of hematology 99 (4) (2024)
Alba Rodríguez-García, Andrés Arroyo, Roberto García-Vicente, Maria Luz Morales, Rubén Gómez-Gordo, Pablo Justo, Clara Cuéllar, José María Sánchez-Pina, Nieves López-Muñoz, Rafael Alonso Fernández, Noemi Puig, Maria-Victoria Mateos-Manteca, Rosa María Ayala, Maria Dulcenombre Gómez-Garré, Joaquin Martinez Lopez, María Linares
Short-Chain Fatty Acid Production by Gut Microbiota Predicts Treatment Response in Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (4) (2024)
Alberto Hernandez-Sanchez, Ángela Villaverde-Ramiro, Eduardo Arellano-Rodrigo, Marta Garrote, Iván Martín, Adrián Mosquera Orgueira, María-Teresa Gómez-Casares, Francisca Ferrer-Marín, Esperanza Such, Patricia Velez, Rosa María Ayala, Anna Angona, Natalia de Las Heras, Elena Magro, María-Isabel Mata-Vázquez, María-Laura Fox, Sonia González de Villambrosía, María-José Ramírez, Ana García, J Valentín García-Gutiérrez, Amparo Cáceres, María-Antonia Durán, Alicia Senín, José-María Raya, José Antonio González, Beatriz Cuevas, Blanca Xicoy Cirici, Manuel Mateo Pérez Encinas, Beatriz Bellosillo, Alberto Álvarez-Larrán, Jesús María Hernández-Rivas, Juan Carlos Carlos Hernández-Boluda, null null
The prognostic impact of non-driver gene mutations and variant allele frequency in primary myelofibrosis. American journal of hematology 99 (4) (2024)
Larissa Haertle, Natalia Buenache, Hipólito Nicolás Cuesta Hernández, Michal Simicek, Renata Snaurova, Inmaculada Rapado, Nerea Martinez, Nieves López-Muñoz, José María Sánchez-Pina, Umair Munawar, Seungbin Han, Yanira Ruiz-Heredia, Rafael Colmenares, Miguel Gallardo, Margarita Sánchez-Beato, Miguel Angel Piris, Mehmet Kemal Samur, Nikhil C Munshi, Rosa María Ayala, Klaus Martin Kortüm, Santiago Barrio, Joaquin Martinez Lopez
Genetic Alterations in Members of the Proteasome 26S Subunit, AAA-ATPase ( PSMC ) Gene Family in the Light of Proteasome Inhibitor Resistance in Multiple Myeloma. Cancers 15 (2) (2023)
Claudia Sargas, Rosa María Ayala, María J Larráyoz, María C Chillón, Eduardo Rodríguez Arbolí, Cristina Bilbao, Esther Prados de la Torre, David Martínez-Cuadrón, Rebeca Rodriguez-Veiga, Blanca Boluda, Cristina Gil, Teresa Bernal, Juan-Miguel Bergua, Lorenzo Algarra, María Del Mar Tormo Díaz, Pilar Martínez-Sánchez, Elena Soria, Josefina Serrano, Juan Manuel Alonso-Domínguez, Raimundo García, María Luz Amigo, Pilar Herrera-Puente, María J Sayas, Esperanza Lavilla-Rubira, Joaquín Martínez-López, María-José Calasanz, Miriam Santero, José Antonio Pérez-Simón, María T Gómez Casares, Joaquín Sánchez-García, Eva Barragán, Pau Montesinos, null null
Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group. Blood cancer journal 13 (1) (2023)
Alba Rodríguez-García, Andrés Arroyo, Roberto García-Vicente, Maria Luz Morales, Rubén Gómez-Gordo, Pablo Justo, Clara Cuéllar, José María Sánchez-Pina, Nieves López-Muñoz, Rafael Alonso Fernández, Noemi Puig, Maria-Victoria Mateos-Manteca, Rosa María Ayala, Maria Dulcenombre Gómez-Garré, Joaquin Martinez Lopez, María Linares
Short-chain fatty acid production by gut microbiota predicts treatment response in multiple myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Claudia Sargas, Rosa María Ayala, María José Larráyoz, María Carmen Chillón, Estrella Carrillo-Cruz, Cristina Bilbao-Sieyro, Esther Prados de la Torre, David Martínez-Cuadrón, Rebeca Rodríguez-Veiga, Blanca Boluda, Cristina Gil, Teresa Bernal Del Castillo, Juan Miguel Bergua, Lorenzo Algarra, María Del Mar Tormo Díaz, Pilar Martínez-Sánchez, Elena Soria, Josefina Serrano, Juan Manuel Alonso-Domínguez, Raimundo García-Boyero, María Luz Amigo, Pilar Herrera-Puente, María José Sayas, Esperanza Lavilla-Rubira, Joaquin Martinez Lopez, María-José Calasanz, Miriam Santero, José Antonio Pérez-Simón, María Teresa Gómez-Casares, Joaquín Sánchez-García, Eva Barragán, Pau Montesinos, null On Behalf Of Pethema Group
Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry. Cancers 15 (2) (2023)
Rosa María Ayala, Rafael Alonso Fernández, Valentín García-Gutiérrez, Alberto Álvarez-Larrán, Santiago Osorio, José María Sánchez-Pina, Gonzalo Carreño-Tarragona, Noemi Álvarez, María Teresa Gómez-Casares, Antonia Duran, Julian Gorrochategi, Juan Carlos Carlos Hernández-Boluda, Joaquin Martinez-Lopez
Janus kinase inhibitor ruxolitinib in combination with nilotinib and prednisone in patients with myelofibrosis (RuNiC study): A phase Ib, multicenter study. EJHaem 4 (2) (2023)
Claudia Sargas, Rosa María Ayala, María J Larráyoz, María C Chillón, Eduardo Rodríguez Arbolí, Cristina Bilbao, Esther Prados de la Torre, David Martínez-Cuadrón, Rebeca Rodriguez-Veiga, Blanca Boluda, Cristina Gil, Teresa Bernal, Juan-Miguel Bergua, Lorenzo Algarra, María Del Mar Tormo Díaz, Pilar Martínez-Sánchez, Elena Soria, Josefina Serrano, Juan Manuel Alonso-Domínguez, Raimundo García, María Luz Amigo, Pilar Herrera-Puente, María J Sayas, Esperanza Lavilla-Rubira, Joaquín Martínez-López, María-José Calasanz, Miriam Santero, José Antonio Pérez-Simón, María T Gómez Casares, Joaquín Sánchez-García, Eva Barragán, Pau Montesinos, null null
Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group. Blood cancer journal 13 (1) (2023)
Claudia Sargas, Rosa María Ayala, María José Larráyoz, María Carmen Chillón, Estrella Carrillo-Cruz, Cristina Bilbao-Sieyro, Esther Prados de la Torre, David Martínez-Cuadrón, Rebeca Rodríguez-Veiga, Blanca Boluda, Cristina Gil, Teresa Bernal Del Castillo, Juan Miguel Bergua, Lorenzo Algarra, María Del Mar Tormo Díaz, Pilar Martínez-Sánchez, Elena Soria, Josefina Serrano, Juan Manuel Alonso-Domínguez, Raimundo García-Boyero, María Luz Amigo, Pilar Herrera-Puente, María José Sayas, Esperanza Lavilla-Rubira, Joaquin Martinez Lopez, María-José Calasanz, Miriam Santero, José Antonio Pérez-Simón, María Teresa Gómez-Casares, Joaquín Sánchez-García, Eva Barragán, Pau Montesinos, null On Behalf Of Pethema Group
Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry. Cancers 15 (2) (2023)
Catia Simoes, Sara Villar, Beñat Ariceta, Juan-José Garcés, Leire Burgos, Diego Alignani, Sarai Sarvide, David Martínez-Cuadrón, Juan-Miguel Bergua, Susana Vives, Lorenzo Algarra, Mar Tormo, Pilar Martinez, Josefina Serrano, Pilar Herrera, Fernando Ramos, Olga Salamero, Esperanza Lavilla, Cristina Gil, Jose-Luis Lopez-Lorenzo, Maria-Belen Vidriales, Carmen Chillon, Jorge Labrador, Jose-Francisco Falantes, María-José Sayas, Rosa María Ayala, Joaquin Martinez Lopez, Ana Alfonso Pierola, María-José Calasanz, Felipe Prosper, Jesús San F Miguel, Miguel Á Sanz, Juan José Lahuerta, Pau Montesinos, null null
Transcriptional and genomic characterization of measurable residual disease in acute myeloid leukaemia. British journal of haematology (2023)
Gonzalo Carreno-Tarragona, Alberto Álvarez-Larrán, Juan Carlos Hernández-Boluda, Rosa María Ayala, Nicholas C P Cross
Should we move to a genomic classification of neutrophilic myeloid neoplasms? Blood advances (2023)
Irene Zamanillo, Lucia Medina de Alba, Rodrigo Gil, Rosalia de la Puerta, Rafael Alonso, Ana Jimenez-Ubieto, María-Teresa Cedena, Maria Calbacho, Rosa María Ayala, Joaquin Martinez Lopez
Clinical Outcomes of Patients with Multiple Myeloma after Daratumumab Failure. Life (Basel, Switzerland) 13 (9) (2023)
Rosa María Ayala, Rafael Alonso Fernández, Valentín García-Gutiérrez, Alberto Álvarez-Larrán, Santiago Osorio, José María Sánchez-Pina, Gonzalo Carreño-Tarragona, Noemi Álvarez, María Teresa Gómez-Casares, Antonia Duran, Julian Gorrochategi, Juan Carlos Carlos Hernández-Boluda, Joaquin Martinez-Lopez
Janus kinase inhibitor ruxolitinib in combination with nilotinib and prednisone in patients with myelofibrosis (RuNiC study): A phase Ib, multicenter study. EJHaem 4 (2) (2023)
Larissa Haertle, Natalia Buenache, Hipólito Nicolás Cuesta Hernández, Michal Simicek, Renata Snaurova, Inmaculada Rapado, Nerea Martinez, Nieves López-Muñoz, José María Sánchez-Pina, Umair Munawar, Seungbin Han, Yanira Ruiz-Heredia, Rafael Colmenares, Miguel Gallardo, Margarita Sánchez-Beato, Miguel Angel Piris, Mehmet Kemal Samur, Nikhil C Munshi, Rosa María Ayala, Klaus Martin Kortüm, Santiago Barrio, Joaquin Martinez Lopez
Genetic Alterations in Members of the Proteasome 26S Subunit, AAA-ATPase ( PSMC ) Gene Family in the Light of Proteasome Inhibitor Resistance in Multiple Myeloma. Cancers 15 (2) (2023)
Rosa María Ayala, Rafael Alonso Fernández, Valentín García-Gutiérrez, Alberto Álvarez-Larrán, Santiago Osorio, José María Sánchez-Pina, Gonzalo Carreño-Tarragona, Noemi Álvarez, María Teresa Gómez-Casares, Antonia Duran, Julian Gorrochategi, Juan Carlos Carlos Hernández-Boluda, Joaquin Martinez-Lopez
Janus kinase inhibitor ruxolitinib in combination with nilotinib and prednisone in patients with myelofibrosis (RuNiC study): A phase Ib, multicenter study. EJHaem 4 (2) (2023)
Juan Carlos Carlos Hernández-Boluda, Irene Pastor-Galán, Eduardo Arellano-Rodrigo, José-María Raya, Manuel Pérez-Encinas, Rosa María Ayala, Francisca Ferrer-Marín, Patricia Velez, Elvira Mora, María-Laura Fox, Jesús-María Hernández-Rivas, Blanca Xicoy Cirici, María-Isabel Mata-Vázquez, María García-Fortes, Raúl Pérez-López, Anna Angona, Beatriz Cuevas, Alicia Senín, María-José Ramírez, Angel Ramírez-Payer, María-Teresa Gómez-Casares, Clara Martínez-Valverde, Elena Magro, Juan-Luis Steegmann, María-Antonia Durán, Carmen García-Hernández, Mercedes Gasior, Sonia González de Villambrosia, Alberto Álvarez-Larrán, Arturo Pereira, null null
Predictors of thrombosis and bleeding in 1613 myelofibrosis patients from the Spanish Registry of Myelofibrosis. British journal of haematology 199 (4) (2022)
Juan Manuel Rosa-Rosa, Isabel Cuenca, Alejandro Medina, Iria Vazquez, Andrea Sánchez-delaCruz, Natalia Buenache, Ricardo Sanchez, Cristina Jiménez, Laura Rosinol, Norma C Gutiérrez, Yanira Ruiz-Heredia, Santiago Barrio, Albert Oriol, Maria-Luisa Martin-Ramos, María-Jesús Blanchard, Rosa María Ayala, Rafael Ríos-Tamayo, Anna Sureda, Miguel-Teodoro Hernández, Javier de la Rubia, Gorka Alkorta-Aranburu, Xabier Agirre, Joan Bladé, Maria-Victoria Mateos-Manteca, Juan-José Lahuerta, Jesús F San-Miguel, María-José Calasanz, Miriam Santero, Joaquín Martínez-Lopez
NGS-Based Molecular Karyotyping of Multiple Myeloma: Results from the GEM12 Clinical Trial. Cancers 14 (20) (2022)
Catia Simoes, Maria Carmen Chillon, David Martínez-Cuadrón, María-José Calasanz, María-Belén Vidriales, Iria Vazquez, Montserrat Hernández-Ruano, Beñat Ariceta, Paula Aguirre-Ruiz, Leire Burgos, Diego Alignani, Sarai Sarvide, Sara Villar, Ana Alfonso, Felipe Prosper, Rosa María Ayala, Joaquin Martínez-López, Juan-Miguel Bergua, Susana Vives, Jose Antonio Perez-Simon, María García-Fortes, Teresa Bernal Del Castillo, Mercedes Colorado, Mayte Olave, Juan I Rodríguez-Gutiérrez, Jorge Labrador, Marcos González-Díaz, Jesús San F Miguel, Miguel A Sanz, Pau Montesinos, Juan José Lahuerta
Integrated flow cytometry and sequencing to reconstruct evolutionary patterns from dysplasia to acute myeloid leukemia. Blood advances (2022)
Gonzalo Carreno-Tarragona, Alberto Alvarez-Larran, Claire N Harrison, Jose Carlos Martínez Ávila, Juan Carlos Carlos Hernández-Boluda, Francisca Ferrer-Marín, Deepti H Radia, Elvira Mora Casterá, Sebastian Francis, Teresa González-Martínez, Kathryn Goddard, Manuel Mateo Pérez Encinas, Srinivasan Narayanan, Jose Maria Raya, Vikram Singh, Peter Toth, Xabier Gutiérrez, Paula Amat Martinez, Louisa McIlwaine, Magda Alobaidi, Karan Mayani, Andrew McGregor, Ruth Stuckey, Bethan Psaila, Adrian Segura, Caroline L Alvares, Kerri Davidson, Santiago Osorio, Robert Cutting, Caroline P Sweeney, Laura Rufian, Laura Moreno, Isabel Cuenca, Jeffrey Smith, Maria Luz Morales, Rodrigo Gil-Manso, Ioannis Koutsavlis, Lihui Wang, Adam J Mead, Maria Rozman, Joaquin Martínez-López, Rosa María Ayala, Nicholas C P Cross
CNL and aCML should be considered as single entity based on molecular profiles and outcomes. Blood advances (2022)
Tamara Castaño-Bonilla, Eva Barragán, Claudia Sargas, Alejandro Sanz, Lorenzo Algarra, Pilar Herrera-Puente, Raimundo García-Boyero, Manuel Barrios, David Martínez-Cuadrón, Rebeca Rodriguez-Veiga, Blanca Boluda, Cristina Gil, Josefina Serrano-López, Joaquin Martinez Lopez, María José Sayas-Lloris, María Teresa Olave, Rosalía Riaza-Grau, Teresa Bernal-Del Castillo, María José Larráyoz, Raquel Amigo, Antonio Jiménez-Velasco, Joaquín Sánchez, Rosa María Ayala, Carlos Blas López, Daniel Lainez-González, Juana Serrano-López, Miguel Angel Sanz, Juan Manuel Alonso-Domínguez, Pau Montesinos
No Evidence that CD33 rs12459419 Polymorphism Predicts Gemtuzumab Ozogamicin Response in Consolidation Treatment of Acute Myeloid Leukemia Patients: Experience of the PETHEMA Group. Disease markers 2022 (2022)
Rafael Colmenares, Noemí Álvarez, Santiago Barrio, Joaquin Martinez Lopez, Rosa María Ayala
The Minimal Residual Disease Using Liquid Biopsies in Hematological Malignancies. Cancers 14 (5) (2022)
Rosa María Ayala, Inmaculada Rapado, Esther Onecha, David Martínez-Cuadrón, Gonzalo Carreno-Tarragona, Juan Miguel Bergua, Susana Vives, Jesus Lorenzo Algarra, María Del Mar Tormo Díaz, Pilar Martinez, Josefina Serrano, Pilar Herrera, Fernando Ramos, Olga Salamero, Esperanza Lavilla-Rubira, Cristina Gil, Jose Luis López Lorenzo, María Belén Vidriales, Jorge Labrador-Gomez, José Francisco Falantes, María José Sayas, Juan José Lahuerta, Eva Barragán, Felipe Prosper, Miguel Angel Sanz, Joaquin Martinez Lopez, Pau Montesinos, null On Behalf Of The Programa Para El Estudio de la Terapeutica En Hemopatias Malignas Pethema Cooperative Study Group
The Mutational Landscape of Acute Myeloid Leukaemia Predicts Responses and Outcomes in Elderly Patients from the PETHEMA-FLUGAZA Phase 3 Clinical Trial. Cancers 13 (10) (2021)
Leila N Varghese, Gonzalo Carreno-Tarragona, Gabriel Levy, Xabier Gutiérrez-López de Ocáriz, Inmaculada Rapado, Joaquín Martínez-López, Rosa María Ayala, Stefan N Constantinescu
MPL S505C enhances driver mutations at W515 in essential thrombocythemia. Blood cancer journal 11 (11) (2021)
Joaquin Martinez Lopez, G Hernandez-Ibarburu, R Alonso, J M Sanchez-Pina, I Zamanillo, N Lopez-Muñoz, Rodrigo Iñiguez, Clara Cuéllar, Maria Calbacho, M L Paciello, Rosa María Ayala, N García-Barrio, D Perez-Rey, L Meloni, Jaime Cruz-Rojo, Miguel Pedrera Jiménez, Pablo Serrano Balazote, J de la Cruz
Impact of COVID-19 in patients with multiple myeloma based on a global data network. Blood cancer journal 11 (12) (2021)
Gonzalo Carreno-Tarragona, Leila N Varghese, Elena Sebastián, Eva Gálvez, Alberto Marín-Sánchez, Nieves López-Muñoz, Syonghyun Nam-Cha, Joaquín Martínez-López, Stefan N Constantinescu, Julian Sevilla, Rosa María Ayala
A typical acute lymphoblastic leukemia JAK2 variant, R683G, causes an aggressive form of familial thrombocytosis when germline. Leukemia 35 (11) (2021)
María Esther Onecha de la Fuente, Yanira Ruiz-Heredia, David Martínez-Cuadrón, Eva Barragán, Pilar Martinez-Sanchez, María Linares, Inmaculada Rapado, Jaime Perez-Oteyza, Elena Magro, Pilar Herrera, José Luis Rojas, Julián Gorrochategui, Jesús Villoria, Blanca Boluda, Claudia Sargas, Joan Ballesteros, Pau Montesinos, Joaquín Martínez-López, Rosa María Ayala
Improving the prediction of acute myeloid leukaemia outcomes by complementing mutational profiling with ex vivo chemosensitivity. British journal of haematology 189 (4) (2020)
Sara Mellid, Javier Coloma, Bruna Calsina, María Monteagudo, Juan M Roldán-Romero, María Santos, Luis Javier Leandro-García, Javier Lanillos, Ángel M Martínez-Montes, Cristina Rodríguez-Antona, Cristina Montero-Conde, Joaquín Martínez-López, Rosa María Ayala, Xavier Matias-Guiu, Mercedes Robledo, Alberto Cascón
Novel DNMT3A Germline Variant in a Patient with Multiple Paragangliomas and Papillary Thyroid Carcinoma. Cancers 12 (11) (2020)
Alba Rodríguez-García, Maria Luz Morales, Vanesa Garrido-García, Irene García-Baquero, Alejandra Leivas, Gonzalo Carreño-Tarragona, Ricardo Sanchez, Alicia Arenas, María-Teresa Cedena, Rosa María Ayala, José M Bautista, Joaquín Martínez-López, María Linares
Protein Carbonylation in Patients with Myelodysplastic Syndrome: An Opportunity for Deferasirox Therapy. Antioxidants (Basel, Switzerland) 8 (11) (2019)

Rosa María Ayala.css-eqlu8i{font-size:small;padding-left:4px;} (R Ayala, Rosa Ayala)

Publication Activity (10 Years)

Top Topics

Top Venues

Rosa María Ayala (R Ayala, Rosa Ayala)